ZL-65

N/A

Report date: 2026/01/15 16:24:26
NME

Base Information

Drug NameZL-65
Drug Alias NameZL-65ZL65
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCryopyrin-Associated Periodic SyndromesHereditary Autoinflammatory DiseasesNeuritis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Zenitar Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Zenitar Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCryopyrin-Associated Periodic SyndromesHereditary Autoinflammatory DiseasesNeuritis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A